Page last updated: 2024-12-08

tetrahymanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tetrahymanol: minor descriptor (75-82); online & Index Medicus search TRITERPENES (75-82) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

tetrahymanol : A pentacyclic triterpenoid having a 3beta- (21alpha-) hydroxy-substituted gammacerane structure. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID168951
CHEMBL ID485801
CHEBI ID9493
SCHEMBL ID1401904
MeSH IDM0262465

Synonyms (18)

Synonym
gammaceran-21alpha-ol
CHEBI:9493 ,
gammaceran-3beta-ol
C06083
tetrahymanol
2130-17-8
LMPR0106210001
CHEMBL485801
(3s,4ar,6ar,6ar,6br,8as,12as,14ar,14br)-4,4,6a,6b,9,9,12a,14b-octamethyl-1,2,3,4a,5,6,6a,7,8,8a,10,11,12,13,14,14a-hexadecahydropicen-3-ol
gammaceran-3-ol, (3beta)-
SCHEMBL1401904
gammaceran-3-ol
wallichiniol
DTXSID60943803
Q27108407
HY-N8781
CS-0149050
AKOS040762424

Research Excerpts

Overview

Tetrahymanol is a polycyclic triterpenoid lipid first discovered in the ciliate Tetrahymena pyriformis. Its potential diagenetic product, gammacerane, is often used as a biomarker for water column stratification in ancient ecosystems.

ExcerptReferenceRelevance
"Tetrahymanol is a polycyclic triterpenoid lipid first discovered in the ciliate Tetrahymena pyriformis whose potential diagenetic product, gammacerane, is often used as a biomarker for water column stratification in ancient ecosystems. "( A distinct pathway for tetrahymanol synthesis in bacteria.
Banta, AB; Wei, JH; Welander, PV, 2015
)
2.17
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pentacyclic triterpenoid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
hopanoid biosynthesis (bacteria)830

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (50.00)18.7374
1990's3 (18.75)18.2507
2000's0 (0.00)29.6817
2010's5 (31.25)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.65 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.19 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]